UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | February 13, 2008 |
UnitedHealth Group Incorporated
__________________________________________
(Exact name of registrant as specified in its charter)
Minnesota | 0-10864 | 41-1321939 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota | 55343 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 952-936-1300 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On February 13, 2008, the New York Attorney General announced that (1) he is conducting an industry-wide investigation into health insurers' provider reimbursement practices; (2) he has issued subpoenas to 16 health insurance companies in connection with such investigation, including UnitedHealth Group Incorporated (the "Company"); and (3) he intends to file suit against the Company and four of its subsidiaries.
No lawsuit has been filed against the Company and its subsidiaries as of February 14, 2008. A copy of the Company's press release in response to these matters is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
99.1 Press Release dated February 13, 2008
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
UnitedHealth Group Incorporated | ||||
February 14, 2008 | By: |
Christopher J. Walsh
|
||
|
||||
Name: Christopher J. Walsh | ||||
Title: Senior Vice President and Deputy General Counsel |
Exhibit Index
Exhibit No. | Description | |
|
|
|
99.1
|
Press Release dated February 13, 2008 |